English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

In 1936 St. Rusznyak and A. Szent-Gyorgyi described, in a paper in Nature (Rusznyak & Szent-Gyorgy, 1936), the relief of certain pathological conditions, characterized by an increased permeability or fragility of the capillary wall, by extracts of Hungarian red pepper containing flavonols, a type of flavonoids, which were then named “vitamin P”. The following five decades saw a slow but steady rise in the interest in the group of flavonoids, and their benefits in the treatment of a vast number of diseases and conditions, including pregnancy toxaemia, rheumatic fever, diabetes and cancer. In the late 1980s and throughout the 1990s flavonoids were intensely studied concerning their actions as mutagenic agents and as antioxidants and pro-oxidants as their likely roles in biological systems (for example, Aviram & Fuhrman, 1998; Lambert & Elias, 2010). In the early 90s the antioxidant activity of flavonoids was extensively studied in vitro, and it was assumed that such activity would be at the basis of the health promoting benefits of these compounds. However, in the late 90s and early 00s the metabolism of flavonoids was deeply scrutinized, and the results indicated that their antioxidant activity in vivo could not account for the overall actions attributed to them (Fraga et al., 2010). The paradigm for flavonoid action changed towards the establishment of flavonoids as inflammation modulators, and more recently their role in neuroprotection, memory and cognition has been under scrutiny (Gomes et al., 2008; Spencer et al., 2009; Spencer, 2010). However, exact mechanisms for many of the actions attributed to flavonoids have not yet been established, but the relationship between their activity and the presence of specific functional groups in the molecules is undeniable. Moreover, each role attributed to flavonoids has been linked to different structural features – for example, while antioxidant activity depends essentially on the number and location of OH groups in the molecules, their antagonist effect towards adenosine receptors depends more on the overall planarity than on the hydroxyl groups; in fact, the latter even appear to be counter-productive (Gonzalez et al., 2007).

Structural Analysis of Flavonoids and Related Compounds - A Review of Spectroscopic Applications